Developing the next generation of graphene-based platforms for cancer therapeutics: The potential role of reactive oxygen species
Autor: | Tanveer A. Tabish, Shaowei Zhang, Paul G. Winyard |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
STAT3
signal transducer and activator of transcription 3 HIF-1ɑ hypoxia-inducible factor-1 alpha Review Article Photodynamic therapy ROS reactive oxygen species Drug Delivery Systems Neoplasms Humans mAb monoclonal antibody Rb retinoblastoma lcsh:QH301-705.5 GO graphene oxide lcsh:R5-920 PTEN phosphatase and tensin homolog deleted on chromosome 10 Singlet oxygen Gene Transfer Techniques Sp1 specificity protein 1 Theranostics Bioimaging PPa Pyropheophorbide-a Oxidative Stress lcsh:Biology (General) PDT photodynamic therapy Hh hedgehog Nrf2 nuclear factor erythroid-derived 2-like 2 Nanoparticles Graphite NF-ϰB-NF kappa B nuclear factor kappa-light-chain-enhancer of activated B cells Graphene lcsh:Medicine (General) Reactive Oxygen Species AP-1 activator protein-1 |
Zdroj: | Redox Biology Redox Biology, Vol 15, Iss C, Pp 34-40 (2018) |
ISSN: | 2213-2317 |
Popis: | Graphene has a promising future in applications such as disease diagnosis, cancer therapy, drug/gene delivery, bio-imaging and antibacterial approaches owing to graphene's unique physical, chemical and mechanical properties alongside minimal toxicity to normal cells, and photo-stability. However, these unique features and bioavailability of graphene are fraught with uncertainties and concerns for environmental and occupational exposure. Changes in the physicochemical properties of graphene affect biological responses including reactive oxygen species (ROS) production. Lower production of ROS by currently available theranostic agents, e.g. magnetic nanoparticles, carbon nanotubes, gold nanostructures or polymeric nanoparticles, restricts their clinical application in cancer therapy. Oxidative stress induced by graphene accumulated in living organs is due to acellular factors which may affect physiological interactions between graphene and target tissues and cells. Acellular factors include particle size, shape, surface charge, surface containing functional groups, and light activation. Cellular responses such as mitochondrial respiration, graphene-cell interactions and pH of the medium are also determinants of ROS production. The mechanisms of ROS production by graphene and the role of ROS for cancer treatment, are poorly understood. The aim of this review is to set the theoretical basis for further research in developing graphene-based theranostic platforms. |
Databáze: | OpenAIRE |
Externí odkaz: |